Poniard Pharmaceuticals, Inc. (PARD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 28, 2026, 9:30 AM EST
Poniard Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
150.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| RVL Pharmaceuticals | 36.92M |
| Infinity Pharmaceuticals | 2.57M |
| Seelos Therapeutics | 2.01M |
| Notable Labs | 313.00K |
| Q BioMed | 209.29K |
| Marizyme | 183.42K |
| NanoLogix | 1.27K |
| Navidea Biopharmaceuticals | 610.00 |